Report Description

United States Cancer Biomarker Market Opportunities, 2011 - 2021

United States Cancer Biomarker Market Opportunities, 2011 - 2021
  • Publish Date:February, 2016
  • Format : PDF
  • Pages : 117

As per the American Cancer Society estimates, the number of cancer cases in the United States is estimated to have stood at 1,658,370 in 2015. With growing incidence rate of cancer in the country, the demand for cancer biomarker for better diagnosis is also increasing at a robust pace. In the US, growing consumption of alcohol and high smoking prevalence coupled with poor dietary habits and sedentary lifestyle of the citizens is increasing cancer risk among the country’s population. Moreover, increasing government funding for cancer biomarker research, coupled with growing use of biomarkers in drug discovery development and clinical trials is further anticipated to fuel cancer biomarker market in the US over the next five years.

“United States Cancer Biomarker Market Opportunities, 2011 - 2021” report studies the market size and share of various segments and sub-segments of the cancer biomarker market in the United States during the period 2011 - 2021. In the study, the market has been categorized into five broader segments that include Immunoassay, Omics Technology, Cytogenetic Technology, Imaging Technology and Bioinformatics.

The market dynamics section of the report elaborates the factors that are driving the market as well as the challenges inhibiting growth. The research study also includes insights of the key market trends, a detailed analysis of the changing competitive landscape, and revenue forecasts for each segment and sub-segment.

All this information is provided to assist the established market players and new entrants in taking their strategic decisions, thereby aiding them in strengthening their market position in a highly competitive cancer biomarker market in the United States.

“United States Cancer Biomarker Market Opportunities, 2011 - 2021” report elaborates the following aspects of cancer biomarker market in the United States:

ü  United States Cancer Biomarker Market Size, Share & Forecast

ü  Segmental Analysis – By Profiling Technology (Immunoassay, Omics Technology, Cytogenetic Technology, Imaging Technology & Bioinformatics), By Application (Drug Discovery and Development, Diagnosis, Prognostic, Risk Assessment & Others), By End User (Contract Research Organizations (CROs) and Drug Manufacturers & Healthcare Providers), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer & Others)

ü  Policy & Regulatory Landscape

ü  Changing Market Trends & Emerging Opportunities

ü  Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

ü  To identify the on-going trends and anticipated growth in the next five years

ü  To gain competitive knowledge of leading market players

ü  To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer’s specific needs   

Key Questions This Study Will Answer

ü  What would be the segmental and regional growth trends in the United States cancer biomarker market in the coming years?

ü  What are the most important growth drivers and opportunities in the market?

ü  Which profiling technology is preferred the most?

ü  What strategies should market competitors employ to gain share in mature segments of the United States cancer biomarker market?

ü  What are the competitor profiles in this market and how do they compete for market share?

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with cancer biomarker manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Please Select Format

Single User License

$2500

Single User License Print

$3000

Enterprise License

$5000

For Queries Please Contact us

sales@pharmaion.com

+1 646 862 0089

10% Customization